DeepMed Research

Rogel Cancer Center: University of Michigan

🇺🇸United States

Country: 🇺🇸United States

Ownership: Subsidiary

Established: 1991-01-01

Employees: -

Market Cap: -

Website: http://www.rogelcancercenter.org

Clinical Trials

The Genetic Information and Family Testing (GIFT) Study

Not Applicable

Conditions: Cancer

Interventions: Genetic: GIFT

First Posted Date: 2022-09-23

Last Posted Date: 2024-11-26

Lead Sponsor: University of Michigan Rogel Cancer Center

Target Recruit Count: 2464

Registration Number: NCT05552664

Locations: 🇺🇸
University of Southern California, Los Angeles, California, United States
🇺🇸
Stanford University, Stanford, California, United States
🇺🇸
Emory University, Atlanta, Georgia, United States

and more 1 locations

Pharmacokinetic Study of Skeletal Muscle Area-based Paclitaxel Infusion in Patients With Cancer

Phase 4

Recruiting

Conditions: Breast Cancer
Metastatic Gastric Cancer
Esophageal Cancer

Interventions: Drug: Paclitaxel

First Posted Date: 2022-01-10

Last Posted Date: 2025-04-02

Lead Sponsor: University of Michigan Rogel Cancer Center

Target Recruit Count: 22

Registration Number: NCT05183126

Locations: 🇺🇸
University of Michigan Rogel Cancer Center, Ann Arbor, Michigan, United States

Hepatic Ablation of Melanoma Metastases to Enhance Immunotherapy Response, a Phase I Clinical Trial (HAMMER I)

Phase 1

Completed

Conditions: Melanoma, Cutaneous
Metastatic Melanoma
Melanoma, Mucosal
Melanoma, Ocular
Liver Metastases

Interventions: Drug: Ipilimumab
Drug: Nivolumab
Procedure: Stereotactic Body Radiation Therapy

First Posted Date: 2021-12-27

Last Posted Date: 2024-11-05

Lead Sponsor: University of Michigan Rogel Cancer Center

Target Recruit Count: 2

Registration Number: NCT05169957

Locations: 🇺🇸
University of Michigan Rogel Cancer Center, Ann Arbor, Michigan, United States

Methods for Increasing Genetic Testing Uptake in Michigan

Not Applicable

Active, not recruiting

Conditions: Colorectal Cancer
Pancreatic Cancer
History of Cancer
Ovarian Cancer
Endometrial Cancer
Breast Cancer
Prostate Cancer

Interventions: Other: Publicly available genetic testing resources
Behavioral: Motivational interviewing (MI)
Behavioral: Virtual genetics navigator

First Posted Date: 2021-12-17

Last Posted Date: 2025-03-14

Lead Sponsor: University of Michigan Rogel Cancer Center

Target Recruit Count: 831

Registration Number: NCT05162846

Locations: 🇺🇸
University of Michigan Rogel Cancer Center, Ann Arbor, Michigan, United States

Avoiding Low-value Treatments in Older Women With Early-stage Breast Cancer: Piloting a Patient Decision Aid

Not Applicable

Completed

Conditions: Breast Cancer

Interventions: Behavioral: Breast cancer decision aid

First Posted Date: 2021-12-01

Last Posted Date: 2023-12-20

Lead Sponsor: University of Michigan Rogel Cancer Center

Target Recruit Count: 22

Registration Number: NCT05140252

Locations: 🇺🇸
University of Michigan Rogel Cancer Center, Ann Arbor, Michigan, United States

Developing a Psychosexual Educational Partners Program: PEPP A Feasibility Study

Not Applicable

Completed

Conditions: Breast Cancer
Gynecologic Cancer

Interventions: Behavioral: Psychosexual Educational Partner Program (PEPP)

First Posted Date: 2021-10-07

Last Posted Date: 2023-02-13

Lead Sponsor: University of Michigan Rogel Cancer Center

Target Recruit Count: 18

Registration Number: NCT05070299

Locations: 🇺🇸
University of Michigan Rogel Cancer Center, Ann Arbor, Michigan, United States

Post-prostatectomy Radiation Therapy--Moderate Versus Ultra-hypofractionated (Also Known as Stereotactic Body Radiation Therapy [SBRT])

Phase 2

Recruiting

Conditions: Prostate Cancer

Interventions: Radiation: Ultra-hypofractionated radiation therapy
Radiation: Moderately Hypo-fractionated Radiation Therapy

First Posted Date: 2021-09-09

Last Posted Date: 2025-01-16

Lead Sponsor: University of Michigan Rogel Cancer Center

Target Recruit Count: 136

Registration Number: NCT05038332

Locations: 🇺🇸
University of Michigan Rogel Cancer Center, Ann Arbor, Michigan, United States

An Attention-Restorative Therapy (ART)-Based Virtual Reality Intervention to Address Cancer-Related Cognitive Impairments Among Breast Cancer Survivors

Not Applicable

Completed

Conditions: Breast Cancer Survivorship
Cancer-related Cognitive Impairment

Interventions: Other: Attention-restorative therapy (ART)-based virtual reality (VR)

First Posted Date: 2021-09-01

Last Posted Date: 2022-11-03

Lead Sponsor: University of Michigan Rogel Cancer Center

Target Recruit Count: 30

Registration Number: NCT05030792

Locations: 🇺🇸
University of Michigan Rogel Cancer Center, Ann Arbor, Michigan, United States

Localized Leiomyosarcoma Biomarker Protocol

Recruiting

Conditions: Leiomyosarcoma

First Posted Date: 2021-06-14

Last Posted Date: 2024-06-24

Lead Sponsor: University of Michigan Rogel Cancer Center

Target Recruit Count: 40

Registration Number: NCT04925089

Locations: 🇺🇸
Vanderbilt University Medical Center, Nashville, Tennessee, United States
🇺🇸
Mayo Clinic, Rochester, Minnesota, United States
🇺🇸
University of Michigan, Ann Arbor, Michigan, United States

Pacritinib in Relapsed/Refractory T-cell Lymphoproliferative Neoplasms

Phase 2

Recruiting

Conditions: T-Cell Neoplasm
Lymphoproliferative Disorders

Interventions: Drug: Pacritinib

First Posted Date: 2021-04-26

Last Posted Date: 2024-11-08

Lead Sponsor: University of Michigan Rogel Cancer Center

Target Recruit Count: 100

Registration Number: NCT04858256

Locations: 🇺🇸
City of Hope, Duarte, California, United States
🇺🇸
Moffitt Cancer Center, Tampa, Florida, United States
🇺🇸
University of Michigan Rogel Cancer Center, Ann Arbor, Michigan, United States

and more 3 locations

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy